Cancer initiation and progression: Involvement of stem cells and the microenvironment

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1775, Issue 2, 2007, Pages 283-297

  Tysnes, Berit B ^a   Bjerkvig, Rolf ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Cancer development; Cancer stem cell; Microenvironment; Stem cell

Indexed keywords

CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL DIVISION; CELL FUSION; CELL RENEWAL; CENTROSOME; DISEASE ASSOCIATION; GENETIC STABILITY; HORIZONTAL GENE TRANSFER; HUMAN; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE REPAIR;

ANTIGENS, CD; CELL DIVISION; CELL FUSION; CENTROSOME; DISEASE PROGRESSION; GENE TRANSFER TECHNIQUES; GENOMIC INSTABILITY; HUMANS; NEOPLASMS; STEM CELLS;

EID: 34250190230     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2007.01.001     Document Type: Review

References (237)

1. Grander D. How do mutated oncogenes and tumor suppressor genes cause cancer?. Med. Oncol. 15 (1998) 20-26
2. Lodish H., Berk A., Zipursky L., Matsudaira P., Baltimore D., and Darnell J. Cancer. In: Lodish H., Berk A., Zipursky L., Matsudaira P., Baltimore D., and Darnell J. (Eds). Molecular Cell Biology (1999), W. H. Freeman and Company, New York 1054-1084
3. Nowell P.C. The clonal evolution of tumor cell populations. Science 194 (1976) 23-28
4. Mueller M.M., and Fusenig N.E. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat. Rev., Cancer 4 (2004) 839-849
5. Heppner G.H., and Miller F.R. The cellular basis of tumor progression. Int. Rev. Cytol. 177 (1998) 1-56
6. Werb Z., and Evans G. Oncogenes and cell proliferation: maintenance of genomic integrity, tumor stem cells, and the somatic microenvironment. Curr. Opin. Genet. Dev. 14 (2004) 1-3
7. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
8. Sieber O.M., Heinimann K., and Tomlinson I.P. Genomic instability-The engine of tumorigenesis?. Nat. Rev., Cancer 3 (2003) 701-708
9. Friedberg E.C., McDaniel L.D., and Schultz R.A. The role of endogenous and exogenous DNA damage and mutagenesis. Curr. Opin. Genet. Dev. 14 (2004) 5-10
10. Motoyama N., and Naka K. DNA damage tumor suppressor genes and genomic instability. Curr. Opin. Genet. Dev. 14 (2004) 11-16
11. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev., Cancer 3 (2003) 155-168
12. Venkitaraman A.R. Tracing the network connecting BRCA and Fanconi anaemia proteins. Nat. Rev., Cancer 4 (2004) 266-276
13. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Orntoft T., Lukas J., and Bartek J. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005) 864-870
14. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., Venere M., Ditullio Jr. R.A., Kastrinakis N.G., Levy B., Kletsas D., Yoneta A., Herlyn M., Kittas C., and Halazonetis T.D. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 (2005) 907-913
15. Loeb L.A., Loeb K.R., and Anderson J.P. Multiple mutations and cancer. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 776-781
16. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
17. Michor F., Iwasa Y., Vogelstein B., Lengauer C., and Nowak M.A. Can chromosomal instability initiate tumorigenesis?. Semin. Cancer Biol. 15 (2005) 43-49
18. Rajagopalan H., and Lengauer C. Aneuploidy and cancer. Nature 432 (2004) 338-341
19. Duesberg P., Fabarius A., and Hehlmann R. Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells. IUBMB Life 56 (2004) 65-81
20. Duesberg P. Does aneuploidy or mutation start cancer?. Science 307 (2005) 41
21. McDermott K.M., Zhang J., Holst C.R., Kozakiewicz B.K., Singla V., and Tlsty T.D. p16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol. 4 (2006) e51
22. Doxsey S. The centrosome-A tiny organelle with big potential. Nat. Genet. 20 (1998) 104-106
23. Lingle W.L., Barrett S.L., Negron V.C., D'Assoro A.B., Boeneman K., Liu W., Whitehead C.M., Reynolds C., and Salisbury J.L. Centrosome amplification drives chromosomal instability in breast tumor development. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 1978-1983
24. Loeb L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51 (1991) 3075-3079
25. Bignold L.P. Chaotic genomes make chaotic cells: the mutator phenotype theory of carcinogenesis applied to clinicopathological relationships of solid tumors. Cancer Invest. 22 (2004) 338-343
26. Donjacour A.A., and Cunha G.R. Stromal regulation of epithelial function. Cancer Treat. Res. 53 (1991) 335-364
27. Sternlicht M.D., Lochter A., Sympson C.J., Huey B., Rougier J.P., Gray J.W., Pinkel D., Bissell M.J., and Werb Z. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98 (1999) 137-146
28. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., Mohar A., Verastegui E., and Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
29. Szabowski A., Maas-Szabowski N., Andrecht S., Kolbus A., Schorpp-Kistner M., Fusenig N.E., and Angel P. c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 103 (2000) 745-755
30. Al-Hajj M., Becker M.W., Wicha M., Weissman I., and Clarke M.F. Therapeutic implications of cancer stem cells. Curr. Opin. Genet. Dev. 14 (2004) 43-47
31. Bixby S., Kruger G.M., Mosher J.T., Joseph N.M., and Morrison S.J. Cell-intrinsic differences between stem cells from different regions of the peripheral nervous system regulate the generation of neural diversity. Neuron 35 (2002) 643-656
32. Sell S. Stem cell origin of cancer and differentiation therapy. Crit. Rev. Oncol. Hematol. 51 (2004) 1-28
33. Houghton J., Morozov A., Smirnova I., and Wang T.C. Stem cells and cancer. Semin. Cancer Biol. (2006) 10.1016/j.semcancer.2006.04.003
34. Wicha M.S., Liu S., and Dontu G. Cancer stem cells: an old idea-A paradigm shift. Cancer Res. 66 (2006) 1883-1890 (discussion 1895-1886)
35. Park C.H., Bergsagel D.E., and McCulloch E.A. Mouse myeloma tumor stem cells: a primary cell culture assay. J. Natl. Cancer Inst. 46 (1971) 411-422
36. Bruce W.R., and Van Der Gaag H. A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 199 (1963) 79-80
37. Wodinsky I., and Kensler C.J. Growth of L1210 leukemia cells. Nature 210 (1966) 962
38. Bergsagel D.E., and Valeriote F.A. Growth characteristics of a mouse plasma cell tumor. Cancer Res. 28 (1968) 2187-2196
39. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., and Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
40. Bhatia M., Wang J.C., Kapp U., Bonnet D., and Dick J.E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 5320-5325
41. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 (1997) 730-737
42. Blair A., Hogge D.E., Ailles L.E., Lansdorp P.M., and Sutherland H.J. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 89 (1997) 3104-3112
43. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3983-3988
44. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., and Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63 (2003) 5821-5828
45. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., and Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64 (2004) 7011-7021
46. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
47. Gibbs C.P., Kukekov V.G., Reith J.D., Tchigrinova O., Suslov O.N., Scott E.W., Ghivizzani S.C., Ignatova T.N., and Steindler D.A. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 7 (2005) 967-976
48. Kim C.F., Jackson E.L., Woolfenden A.E., Lawrence S., Babar I., Vogel S., Crowley D., Bronson R.T., and Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121 (2005) 823-835
49. Fang D., Nguyen T.K., Leishear K., Finko R., Kulp A.N., Hotz S., Van Belle P.A., Xu X., Elder D.E., and Herlyn M. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65 (2005) 9328-9337
50. Collins A.T., Berry P.A., Hyde C., Stower M.J., and Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65 (2005) 10946-10951
51. Perez-Losada J., and Balmain A. Stem-cell hierarchy in skin cancer. Nat. Rev., Cancer 3 (2003) 434-443
52. Spradling A., Drummond-Barbosa D., and Kai T. Stem cells find their niche. Nature 414 (2001) 98-104
53. Wallenfang M.R., and Matunis E. Developmental biology. Orienting stem cells. Science 301 (2003) 1490-1491
54. Yamashita Y.M., Jones D.L., and Fuller M.T. Orientation of asymmetric stem cell division by the APC tumor suppressor and centrosome. Science 301 (2003) 1547-1550
55. Horvitz H.R., and Herskowitz I. Mechanisms of asymmetric cell division: two Bs or not two Bs, that is the question. Cell 68 (1992) 237-255
56. Caussinus E., and Gonzalez C. Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster. Nat. Genet. 37 (2005) 1125-1129
57. Bilder D. Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors. Genes Dev. 18 (2004) 1909-1925
58. Roegiers F., and Jan Y.N. Asymmetric cell division. Curr. Opin. Cell Biol. 16 (2004) 195-205
59. Uemura T., Shepherd S., Ackerman L., Jan L.Y., and Jan Y.N. Numb, a gene required in determination of cell fate during sensory organ formation in Drosophila embryos. Cell 58 (1989) 349-360
60. Rhyu M.S., Jan L.Y., and Jan Y.N. Asymmetric distribution of numb protein during division of the sensory organ precursor cell confers distinct fates to daughter cells. Cell 76 (1994) 477-491
61. Zhong W., Feder J.N., Jiang M.M., Jan L.Y., and Jan Y.N. Asymmetric localization of a mammalian numb homolog during mouse cortical neurogenesis. Neuron 17 (1996) 43-53
62. Li H.S., Wang D., Shen Q., Schonemann M.D., Gorski J.A., Jones K.R., Temple S., Jan L.Y., and Jan Y.N. Inactivation of Numb and Numblike in embryonic dorsal forebrain impairs neurogenesis and disrupts cortical morphogenesis. Neuron 40 (2003) 1105-1118
63. Spana E.P., Kopczynski C., Goodman C.S., and Doe C.Q. Asymmetric localization of numb autonomously determines sibling neuron identity in the Drosophila CNS. Development 121 (1995) 3489-3494
64. Ruiz Gomez M., and Bate M. Segregation of myogenic lineages in Drosophila requires numb. Development 124 (1997) 4857-4866
65. Carmena A., Murugasu-Oei B., Menon D., Jimenez F., and Chia W. Inscuteable and numb mediate asymmetric muscle progenitor cell divisions during Drosophila myogenesis. Genes Dev. 12 (1998) 304-315
66. Park M., Yaich L.E., and Bodmer R. Mesodermal cell fate decisions in Drosophila are under the control of the lineage genes numb, Notch, and sanpodo. Mech. Dev. 75 (1998) 117-126
67. Justice N.J., and Jan Y.N. Variations on the Notch pathway in neural development. Curr. Opin. Neurobiol. 12 (2002) 64-70
68. Guo M., Jan L.Y., and Jan Y.N. Control of daughter cell fates during asymmetric division: interaction of Numb and Notch. Neuron 17 (1996) 27-41
69. Le Borgne R., Bardin A., and Schweisguth F. The roles of receptor and ligand endocytosis in regulating Notch signaling. Development 132 (2005) 1751-1762
70. Artavanis-Tsakonas S., Rand M.D., and Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 284 (1999) 770-776
71. Mumm J.S., and Kopan R. Notch signaling: from the outside in. Dev. Biol. 228 (2000) 151-165
72. Pece S., Serresi M., Santolini E., Capra M., Hulleman E., Galimberti V., Zurrida S., Maisonneuve P., Viale G., and Di Fiore P.P. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J. Cell Biol. 167 (2004) 215-221
73. Chen J., Xu J., Zhao W., Hu G., Cheng H., Kang Y., Xie Y., and Lu Y. Characterization of human LNX, a novel ligand of Numb protein X that is downregulated in human gliomas. Int. J. Biochem. Cell Biol. 37 (2005) 2273-2283
74. Pardal R., Clarke M.F., and Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat. Rev., Cancer 3 (2003) 895-902
75. Al-Hajj M., and Clarke M.F. Self-renewal and solid tumor stem cells. Oncogene 23 (2004) 7274-7282
76. Beachy P.A., Karhadkar S.S., and Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 432 (2004) 324-331
77. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J., and Clarke M.F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423 (2003) 302-305
78. Lessard J., and Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423 (2003) 255-260
79. Duncan A.W., Rattis F.M., Dimascio L.N., Congdon K.L., Pazianos G., Zhao C., Yoon K., Cook J.M., Willert K., Gaiano N., and Reya T. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat. Immunol. 6 (2005) 314-322
80. Bhardwaj G., Murdoch B., Wu D., Baker D.P., Williams K.P., Chadwick K., Ling L.E., Karanu F.N., and Bhatia M. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat. Immunol. 2 (2001) 172-180
81. Taipale J., and Beachy P.A. The Hedgehog and Wnt signalling pathways in cancer. Nature 411 (2001) 349-354
82. Weng A.P., and Aster J.C. Multiple niches for Notch in cancer: context is everything. Curr. Opin. Genet. Dev. 14 (2004) 48-54
83. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
84. Reya T., and Clevers H. Wnt signalling in stem cells and cancer. Nature 434 (2005) 843-850
85. Molofsky A.V., Pardal R., and Morrison S.J. Diverse mechanisms regulate stem cell self-renewal. Curr. Opin. Cell Biol. 16 (2004) 700-707
86. Ruiz i Altaba A., Stecca B., and Sanchez P. Hedgehog-Gli signaling in brain tumors: stem cells and paradevelopmental programs in cancer. Cancer Lett. 204 (2004) 145-157
87. Grabher C., von Boehmer H., and Look A.T. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat. Rev., Cancer 6 (2006) 347-359
88. Pasca di Magliano M., and Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat. Rev., Cancer 3 (2003) 903-911
89. Valk-Lingbeek M.E., Bruggeman S.W., and van Lohuizen M. Stem cells and cancer; the polycomb connection. Cell 118 (2004) 409-418
90. Leung C., Lingbeek M., Shakhova O., Liu J., Tanger E., Saremaslani P., Van Lohuizen M., and Marino S. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428 (2004) 337-341
91. Marino S. Medulloblastoma: developmental mechanisms out of control. Trends Mol. Med. 11 (2005) 17-22
92. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
93. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
94. Karin M., and Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev., Immunol. 5 (2005) 749-759
95. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev., Cancer 4 (2004) 71-78
96. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315 (1986) 1650-1659
97. Leek R.D., and Harris A.L. Tumor-associated macrophages in breast cancer. J. Mammary Gland Biol. Neoplasia 7 (2002) 177-189
98. Houghton J., Stoicov C., Nomura S., Rogers A.B., Carlson J., Li H., Cai X., Fox J.G., Goldenring J.R., and Wang T.C. Gastric cancer originating from bone marrow-derived cells. Science 306 (2004) 1568-1571
99. Serakinci N., Guldberg P., Burns J.S., Abdallah B., Schrodder H., Jensen T., and Kassem M. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23 (2004) 5095-5098
100. Wagers A.J., and Weissman I.L. Plasticity of adult stem cells. Cell 116 (2004) 639-648
101. Blau H.M., Brazelton T.R., and Weimann J.M. The evolving concept of a stem cell: entity or function?. Cell 105 (2001) 829-841
102. Terada N., Hamazaki T., Oka M., Hoki M., Mastalerz D.M., Nakano Y., Meyer E.M., Morel L., Petersen B.E., and Scott E.W. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416 (2002) 542-545
103. Ying Q.L., Nichols J., Evans E.P., and Smith A.G. Changing potency by spontaneous fusion. Nature 416 (2002) 545-548
104. Verfaillie C.M. Adult stem cells: assessing the case for pluripotency. Trends Cell Biol. 12 (2002) 502-508
105. Orkin S.H., and Zon L.I. Hematopoiesis and stem cells: plasticity versus developmental heterogeneity. Nat. Immunol. 3 (2002) 323-328
106. Eisenberg L.M., and Eisenberg C.A. Stem cell plasticity, cell fusion, and transdifferentiation. Birth Defects Res. C Embryo Today 69 (2003) 209-218
107. Rodic N., Rutenberg M.S., and Terada N. Cell fusion and reprogramming: resolving our transdifferences. Trends Mol. Med. 10 (2004) 93-96
108. Lemoli R.M., Bertolini F., Cancedda R., De Luca M., Del Santo A., Ferrari G., Ferrari S., Martino G., Mavilio F., and Tura S. Stem cell plasticity: time for a reappraisal?. Haematologica 90 (2005) 360-381
109. Passegue E., Jamieson C.H., Ailles L.E., and Weissman I.L. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?. Proc. Natl. Acad. Sci. U. S. A. 100 Suppl. 1 (2003) 11842-11849
110. Bjerkvig R., Tysnes B.B., Aboody K.S., Najbauer J., and Terzis A.J. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat. Rev., Cancer 5 (2005) 899-904
111. Bissell M.J., and Labarge M.A. Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?. Cancer Cell 7 (2005) 17-23
112. Damelin M., Sun Y.E., Sodja V.B., and Bestor T.H. Decatenation checkpoint deficiency in stem and progenitor cells. Cancer Cell 8 (2005) 479-484
113. Grisendi S., Bernardi R., Rossi M., Cheng K., Khandker L., Manova K., and Pandolfi P.P. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 437 (2005) 147-153
114. Li J., Sejas D.P., Rani R., Koretsky T., Bagby G.C., and Pang Q. Nucleophosmin regulates cell cycle progression and stress response in hematopoietic stem/progenitor cells. J. Biol. Chem. 281 (2006) 16536-16545
115. Hernandez L.D., Hoffman L.R., Wolfsberg T.G., and White J.M. Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev. Biol. 12 (1996) 627-661
116. Ogle B.M., Cascalho M., and Platt J.L. Biological implications of cell fusion. Nat. Rev., Mol. Cell Biol. 6 (2005) 567-575
117. Vignery A. Macrophage fusion: are somatic and cancer cells possible partners?. Trends Cell Biol. 15 (2005) 188-193
118. Camargo F.D., Chambers S.M., and Goodell M.A. Stem cell plasticity: from transdifferentiation to macrophage fusion. Cell Prolif. 37 (2004) 55-65
119. O'Malley K., and Scott E.W. Stem cell fusion confusion. Exp. Hematol. 32 (2004) 131-134
120. Pomerantz J., and Blau H.M. Nuclear reprogramming: a key to stem cell function in regenerative medicine. Nat. Cell Biol. 6 (2004) 810-816
121. Weimann J.M., Johansson C.B., Trejo A., and Blau H.M. Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat. Cell Biol. 5 (2003) 959-966
122. Blau H.M., and Blakely B.T. Plasticity of cell fate: insights from heterokaryons. Semin. Cell Dev. Biol. 10 (1999) 267-272
123. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., Fike J.R., Lee H.O., Pfeffer K., Lois C., Morrison S.J., and Alvarez-Buylla A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425 (2003) 968-973
124. Vassilopoulos G., Wang P.R., and Russell D.W. Transplanted bone marrow regenerates liver by cell fusion. Nature 422 (2003) 901-904
125. O. Aichel, "Vorträge und Aufsätze über Entvickelungsmechanik Der Organismen". Wilhelm Engelmann, Leipzig 1911.
126. Mekler L.B. Hybridization of transformed cells with lymphocytes as 1 of the probable causes of the progression leading to the development of metastatic malignant cells. Vestn. Akad. Med. Nauk SSSR 26 (1971) 80-89
127. Warner T.F. Cell hybridizaiton: an explanation for the phenotypic diversity of certain tumours. Med. Hypotheses 1 (1975) 51-57
128. Larizza L., Schirrmacher V., Graf L., Pfluger E., Peres-Martinez M., and Stohr M. Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage. Int. J. Cancer 34 (1984) 699-707
129. Larizza L., Schirrmacher V., and Pfluger E. Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow-derived macrophage. J. Exp. Med. 160 (1984) 1579-1584
130. Rachkovsky M., Sodi S., Chakraborty A., Avissar Y., Bolognia J., McNiff J.M., Platt J., Bermudes D., and Pawelek J. Melanoma x macrophage hybrids with enhanced metastatic potential. Clin. Exp. Metastasis 16 (1998) 299-312
131. Duelli D., and Lazebnik Y. Cell fusion: a hidden enemy?. Cancer Cell 3 (2003) 445-448
132. Duelli D.M., Hearn S., Myers M.P., and Lazebnik Y. A primate virus generates transformed human cells by fusion. J. Cell Biol. 171 (2005) 493-503
133. Miller F.R., McInerney D., Rogers C., and Miller B.E. Spontaneous fusion between metastatic mammary tumor subpopulations. J. Cell. Biochem. 36 (1988) 129-136
134. Miller F.R., Mohamed A.N., and McEachern D. Production of a more aggressive tumor cell variant by spontaneous fusion of two mouse tumor subpopulations. Cancer Res. 49 (1989) 4316-4321
135. Pawelek J., Chakraborty A., Lazova R., Yilmaz Y., Cooper D., Brash D., and Handerson T. Co-opting macrophage traits in cancer progression: a consequence of tumor cell fusion?. Contrib. Microbiol. 13 (2006) 138-155
136. Barski G., Sorieul S., and Cornefert F. Production of cells of a "hybrid" nature in cultures in vitro of 2 cellular strains in combination. C. R. Hebd. Seances Acad. Sci. 251 (1960) 1825-1827
137. Goldenberg D.M., Pavia R.A., and Tsao M.C. In vivo hybridisation of human tumour and normal hamster cells. Nature 250 (1974) 649-651
138. Clarke M.F., and Fuller M. Stem cells and cancer: two faces of eve. Cell 124 (2006) 1111-1115
139. Ephrussi B., Davidson R.L., Weiss M.C., Harris H., and Klein G. Malignancy of somatic cell hybrids. Nature 224 (1969) 1314-1316
140. Harris H., Wiener F., and Klein G. The analysis of malignancy by cell fusion. 3. Hybrids between diploid fibroblasts and other tumour cells. J. Cell Sci. 8 (1971) 681-692
141. Davidson R.L. Gene expression in somatic cell hybrids. Annu. Rev. Genet. 8 (1974) 195-218
142. Ebeling S.B., Bos H.M., Slater R., Overkamp W.J., Cuthbert A.P., Newbold R.F., Zdzienicka M.Z., and Aarden L.A. Human chromosome 21 determines growth factor dependence in human/mouse B-cell hybridomas. Cancer Res. 58 (1998) 2863-2868
143. Vignery A. Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. Int. J. Exp. Pathol. 81 (2000) 291-304
144. Shemer G., and Podbilewicz B. The story of cell fusion: big lessons from little worms. BioEssays 25 (2003) 672-682
145. Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence?. Nat. Rev., Cancer 2 (2002) 777-785
146. Abate-Shen C. Homeobox genes and cancer: new OCTaves for an old tune. Cancer Cell 4 (2003) 329-330
147. Samuel S., and Naora H. Homeobox gene expression in cancer: insights from developmental regulation and deregulation. Eur. J. Cancer 41 (2005) 2428-2437
148. van der Lugt N.M., Alkema M., Berns A., and Deschamps J. The Polycomb-group homolog Bmi-1 is a regulator of murine Hox gene expression. Mech. Dev. 58 (1996) 153-164
149. Bel-Vialar S., Core N., Terranova R., Goudot V., Boned A., and Djabali M. Altered retinoic acid sensitivity and temporal expression of Hox genes in polycomb-M33-deficient mice. Dev. Biol. 224 (2000) 238-249
150. Kajiume T., Ninomiya Y., Ishihara H., Kanno R., and Kanno M. Polycomb group gene mel-18 modulates the self-renewal activity and cell cycle status of hematopoietic stem cells. Exp. Hematol. 32 (2004) 571-578
151. Briscoe J., Sussel L., Serup P., Hartigan-O'Connor D., Jessell T.M., Rubenstein J.L., and Ericson J. Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling. Nature 398 (1999) 622-627
152. Yun K., Fischman S., Johnson J., Hrabe de Angelis M., Weinmaster G., and Rubenstein J.L. Modulation of the notch signaling by Mash1 and Dlx1/2 regulates sequential specification and differentiation of progenitor cell types in the subcortical telencephalon. Development 129 (2002) 5029-5040
153. Daikoku T., Song H., Guo Y., Riesewijk A., Mosselman S., Das S.K., and Dey S.K. Uterine Msx-1 and Wnt4 signaling becomes aberrant in mice with the loss of leukemia inhibitory factor or Hoxa-10: evidence for a novel cytokine-homeobox-Wnt signaling in implantation. Mol. Endocrinol. 18 (2004) 1238-1250
154. Zakany J., Kmita M., and Duboule D. A dual role for Hox genes in limb anterior-posterior asymmetry. Science 304 (2004) 1669-1672
155. Bergsmedh A., Szeles A., Henriksson M., Bratt A., Folkman M.J., Spetz A.L., and Holmgren L. Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6407-6411
156. Lake J.A., Jain R., and Rivera M.C. Mix and match in the tree of life. Science 283 (1999) 2027-2028
157. Ochman H., Lawrence J.G., and Groisman E.A. Lateral gene transfer and the nature of bacterial innovation. Nature 405 (2000) 299-304
158. Holmgren L., Szeles A., Rajnavolgyi E., Folkman J., Klein G., Ernberg I., and Falk K.I. Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood 93 (1999) 3956-3963
159. Bergsmedh A., Szeles A., Spetz A.L., and Holmgren L. Loss of the p21(Cip1/Waf1) cyclin kinase inhibitor results in propagation of horizontally transferred DNA. Cancer Res. 62 (2002) 575-579
160. Bjerknes R., Bjerkvig R., and Laerum O.D. Phagocytic capacity of normal and malignant rat glial cells in culture. J. Natl. Cancer Inst. 78 (1987) 279-288
161. Rustom A., Saffrich R., Markovic I., Walther P., and Gerdes H.H. Nanotubular highways for intercellular organelle transport. Science 303 (2004) 1007-1010
162. Kramer A., Neben K., and Ho A.D. Centrosome aberrations in hematological malignancies. Cell Biol. Int. 29 (2005) 375-383
163. Rieder C.L., Faruki S., and Khodjakov A. The centrosome in vertebrates: more than a microtubule-organizing center. Trends Cell Biol. 11 (2001) 413-419
164. Wang Q., Hirohashi Y., Furuuchi K., Zhao H., Liu Q., Zhang H., Murali R., Berezov A., Du X., Li B., and Greene M.I. The centrosome in normal and transformed cells. DNA Cell Biol. 23 (2004) 475-489
165. Nigg E.A. Centrosome aberrations: cause or consequence of cancer progression?. Nat. Rev., Cancer 2 (2002) 815-825
166. Storchova Z., and Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev., Mol. Cell Biol. 5 (2004) 45-54
167. Brinkley B.R. Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol. 11 (2001) 18-21
168. Pihan G.A., Purohit A., Wallace J., Knecht H., Woda B., Quesenberry P., and Doxsey S.J. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 58 (1998) 3974-3985
169. McCartney B.M., and Peifer M. Stem cells in the news: CNN and APC make headlines. Dev. Cell 5 (2003) 532-534
170. Siller K.H., Cabernard C., and Doe C.Q. The NuMA-related Mud protein binds Pins and regulates spindle orientation in Drosophila neuroblasts. Nat. Cell Biol. 8 (2006) 594-600
171. Lothschutz D., Jennewein M., Pahl S., Lausberg H.F., Eichler A., Mutschler W., Hanselmann R.G., and Oberringer M. Polyploidization and centrosome hyperamplification in inflammatory bronchi. Inflamm. Res. 51 (2002) 416-422
172. Chae S., Yun C., Um H., Lee J.H., and Cho H. Centrosome amplification and multinuclear phenotypes are Induced by hydrogen peroxide. Exp. Mol. Med. 37 (2005) 482-487
173. Oberringer M., Lothschutz D., Jennewein M., Koschnick M., Mutschler W., and Hanselmann R.G. Centrosome multiplication accompanies a transient clustering of polyploid cells during tissue repair. Mol. Cell Biol. Res. Commun. 2 (1999) 190-196
174. Barthelmes H.U., Grue P., Feineis S., Straub T., and Boege F. Active DNA topoisomerase IIalpha is a component of the salt-stable centrosome core. J. Biol. Chem. 275 (2000) 38823-38830
175. Zeller K.I., Haggerty T.J., Barrett J.F., Guo Q., Wonsey D.R., and Dang C.V. Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. J. Biol. Chem. 276 (2001) 48285-48291
176. Boon K., Caron H.N., van Asperen R., Valentijn L., Hermus M.C., van Sluis P., Roobeek I., Weis I., Voute P.A., Schwab M., and Versteeg R. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J. 20 (2001) 1383-1393
177. Okuda M., Horn H.F., Tarapore P., Tokuyama Y., Smulian A.G., Chan P.K., Knudsen E.S., Hofmann I.A., Snyder J.D., Bove K.E., and Fukasawa K. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103 (2000) 127-140
178. Park C.S., Kim S.I., Lee M.S., Youn C.Y., Kim D.J., Jho E.H., and Song W.K. Modulation of beta-catenin phosphorylation/degradation by cyclin-dependent kinase 2. J. Biol. Chem. 279 (2004) 19592-19599
179. Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., and Mann M. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426 (2003) 570-574
180. Delaval B., Lelievre H., and Birnbaum D. Myeloproliferative disorders: the centrosome connection. Leukemia 19 (2005) 1739-1744
181. T. Boveri, Zellen-Studien IV, Über die Natur der Centrosomen, ed., Jena 1900.
182. Boveri T. Zur Frage der Enstehung maligner Tumoren (1914), Gustav Fischer Verlag, Jena
183. Hansson E.M., Lendahl U., and Chapman G. Notch signaling in development and disease. Semin. Cancer Biol. 14 (2004) 320-328
184. Wu L., and Griffin J.D. Modulation of Notch signaling by mastermind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis. Semin. Cancer Biol. 14 (2004) 348-356
185. Schweisguth F. Notch signaling activity. Curr. Biol. 14 (2004) R129-R138
186. Smalley M.J., and Dale T.C. Wnt signalling in mammalian development and cancer. Cancer Metastasis Rev. 18 (1999) 215-230
187. van Es J.H., Barker N., and Clevers H. You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Curr. Opin. Genet. Dev. 13 (2003) 28-33
188. Behrens J. The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem. Soc. Trans. 33 (2005) 672-675
189. Goodrich L.V., and Scott M.P. Hedgehog and patched in neural development and disease. Neuron 21 (1998) 1243-1257
190. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F., and Morrison S.J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425 (2003) 962-967
191. Jacobs J.J., Kieboom K., Marino S., DePinho R.A., and van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397 (1999) 164-168
192. Sherr C.J. The INK4a/ARF network in tumour suppression. Nat. Rev., Mol. Cell Biol. 2 (2001) 731-737
193. Lowe S.W., and Sherr C.J. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13 (2003) 77-83
194. Rubin J.B., and Rowitch D.H. Medulloblastoma: a problem of developmental biology. Cancer Cell 2 (2002) 7-8
195. Chen H., Rubin E., Zhang H., Chung S., Jie C.C., Garrett E., Biswal S., and Sukumar S. Identification of transcriptional targets of HOXA5. J. Biol. Chem. 280 (2005) 19373-19380
196. Meunier D., Aubin J., and Jeannotte L. Perturbed thyroid morphology and transient hypothyroidism symptoms in Hoxa5 mutant mice. Dev. Dyn. 227 (2003) 367-378
197. Crooks G.M., Fuller J., Petersen D., Izadi P., Malik P., Pattengale P.K., Kohn D.B., and Gasson J.C. Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors. Blood 94 (1999) 519-528
198. Fuller J.F., McAdara J., Yaron Y., Sakaguchi M., Fraser J.K., and Gasson J.C. Characterization of HOX gene expression during myelopoiesis: role of HOX A5 in lineage commitment and maturation. Blood 93 (1999) 3391-3400
199. Raman V., Martensen S.A., Reisman D., Evron E., Odenwald W.F., Jaffee E., Marks J., and Sukumar S. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405 (2000) 974-978
200. Phinney D.G., Gray A.J., Hill K., and Pandey A. Murine mesenchymal and embryonic stem cells express a similar Hox gene profile. Biochem. Biophys. Res. Commun. 338 (2005) 1759-1765
201. Makiyama K., Hamada J., Takada M., Murakawa K., Takahashi Y., Tada M., Tamoto E., Shindo G., Matsunaga A., Teramoto K., Komuro K., Kondo S., Katoh H., Koike T., and Moriuchi T. Aberrant expression of HOX genes in human invasive breast carcinoma. Oncol. Rep. 13 (2005) 673-679
202. Care A., Felicetti F., Meccia E., Bottero L., Parenza M., Stoppacciaro A., Peschle C., and Colombo M.P. HOXB7: a key factor for tumor-associated angiogenic switch. Cancer Res. 61 (2001) 6532-6539
203. Care A., Valtieri M., Mattia G., Meccia E., Masella B., Luchetti L., Felicetti F., Colombo M.P., and Peschle C. Enforced expression of HOXB7 promotes hematopoietic stem cell proliferation and myeloid-restricted progenitor differentiation. Oncogene 18 (1999) 1993-2001
204. Care A., Silvani A., Meccia E., Mattia G., Peschle C., and Colombo M.P. Transduction of the SkBr3 breast carcinoma cell line with the HOXB7 gene induces bFGF expression, increases cell proliferation and reduces growth factor dependence. Oncogene 16 (1998) 3285-3289
205. Care A., Silvani A., Meccia E., Mattia G., Stoppacciaro A., Parmiani G., Peschle C., and Colombo M.P. HOXB7 constitutively activates basic fibroblast growth factor in melanomas. Mol. Cell. Biol. 16 (1996) 4842-4851
206. Meccia E., Bottero L., Felicetti F., Peschle C., Colombo M.P., and Care A. HOXB7 expression is regulated by the transcription factors NF-Y, YY1, Sp1 and USF-1. Biochim. Biophys. Acta 1626 (2003) 1-9
207. Grinberg I., and Millen K.J. The ZIC gene family in development and disease. Clin. Genet. 67 (2005) 290-296
208. Herman G.E., and El-Hodiri H.M. The role of ZIC3 in vertebrate development. Cytogenet. Genome Res. 99 (2002) 229-235
209. Koyabu Y., Nakata K., Mizugishi K., Aruga J., and Mikoshiba K. Physical and functional interactions between Zic and Gli proteins. J. Biol. Chem. 276 (2001) 6889-6892
210. Mizugishi K., Aruga J., Nakata K., and Mikoshiba K. Molecular properties of Zic proteins as transcriptional regulators and their relationship to GLI proteins. J. Biol. Chem. 276 (2001) 2180-2188
211. Ruiz i Altaba A., Sanchez P., and Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat. Rev., Cancer 2 (2002) 361-372
212. Castagnola P., and Giaretti W. Mutant KRAS, chromosomal instability and prognosis in colorectal cancer. Biochim. Biophys. Acta 1756 (2005) 115-125
213. Singh A., Sowjanya A.P., and Ramakrishna G. The wild-type Ras: road ahead. FASEB J. 19 (2005) 161-169
214. Thrane E.V., Becher R., Lag M., Refsnes M., Huitfeldt H.S., and Schwarze P.E. Differential distribution and increased levels of ras proteins during lung development. Exp. Lung Res. 23 (1997) 35-49
215. Pells S., Divjak M., Romanowski P., Impey H., Hawkins N.J., Clarke A.R., Hooper M.L., and Williamson D.J. Developmentally-regulated expression of murine K-ras isoforms. Oncogene 15 (1997) 1781-1786
216. Berns A. Stem cells for lung cancer?. Cell 121 (2005) 811-813
217. Qin P., Haberbusch J.M., Soprano K.J., and Soprano D.R. Retinoic acid regulates the expression of PBX1, PBX2, and PBX3 in P19 cells both transcriptionally and post-translationally. J. Cell Biochem. 92 (2004) 147-163
218. Qin P., Haberbusch J.M., Zhang Z., Soprano K.J., and Soprano D.R. Pre-B cell leukemia transcription factor (PBX) proteins are important mediators for retinoic acid-dependent endodermal and neuronal differentiation of mouse embryonal carcinoma P19 cells. J. Biol. Chem. 279 (2004) 16263-16271
219. Kim S.K., Selleri L., Lee J.S., Zhang A.Y., Gu X., Jacobs Y., and Cleary M.L. Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus. Nat. Genet. 30 (2002) 430-435
220. Yuki Y., Imoto I., Imaizumi M., Hibi S., Kaneko Y., Amagasa T., and Inazawa J. Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13). Cancer Sci. 95 (2004) 503-507
221. Smith K.S., Chanda S.K., Lingbeek M., Ross D.T., Botstein D., van Lohuizen M., and Cleary M.L. Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1. Mol. Cell 12 (2003) 393-400
222. Zhang X., Zhu T., Chen Y., Mertani H.C., Lee K.O., and Lobie P.E. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J. Biol. Chem. 278 (2003) 7580-7590
223. Friedmann Y., Daniel C.A., Strickland P., and Daniel C.W. Hox genes in normal and neoplastic mouse mammary gland. Cancer Res. 54 (1994) 5981-5985
224. Chariot A., Moreau L., Senterre G., Sobel M.E., and Castronovo V. Retinoic acid induces three newly cloned HOXA1 transcripts in MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 215 (1995) 713-720
225. Shawlot W., and Behringer R.R. Requirement for Lim1 in head-organizer function. Nature 374 (1995) 425-430
226. Dong W.F., Heng H.H., Lowsky R., Xu Y., DeCoteau J.F., Shi X.M., Tsui L.C., and Minden M.D. Cloning, expression, and chromosomal localization to 11p12-13 of a human LIM/HOMEOBOX gene, hLim-1. DNA Cell Biol. 16 (1997) 671-678
227. Sato N., Fukushima N., Maitra A., Matsubayashi H., Yeo C.J., Cameron J.L., Hruban R.H., and Goggins M. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res. 63 (2003) 3735-3742
228. Varis A., Wolf M., Monni O., Vakkari M.L., Kokkola A., Moskaluk C., Frierson Jr. H., Powell S.M., Knuutila S., Kallioniemi A., and El-Rifai W. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res. 62 (2002) 2625-2629
229. Kumar R., Wang R.A., and Bagheri-Yarmand R. Emerging roles of MTA family members in human cancers. Semin. Oncol. 30 (2003) 30-37
230. Yao Y.L., and Yang W.M. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J. Biol. Chem. 278 (2003) 42560-42568
231. Lipinski M.M., and Jacks T. The retinoblastoma gene family in differentiation and development. Oncogene 18 (1999) 7873-7882
232. Mulligan G., and Jacks T. The retinoblastoma gene family: cousins with overlapping interests. Trends Genet. 14 (1998) 223-229
233. Classon M., and Dyson N. p107 and p130: versatile proteins with interesting pockets. Exp. Cell Res. 264 (2001) 135-147
234. Classon M., and Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat. Rev., Cancer 2 (2002) 910-917
235. Sage J., Mulligan G.J., Attardi L.D., Miller A., Chen S., Williams B., Theodorou E., and Jacks T. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14 (2000) 3037-3050
236. Claudio P.P., Howard C.M., Pacilio C., Cinti C., Romano G., Minimo C., Maraldi N.M., Minna J.D., Gelbert L., Leoncini L., Tosi G.M., Hicheli P., Caputi M., Giordano G.G., and Giordano A. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. Cancer Res. 60 (2000) 372-382
237. Li Q., Sakurai Y., Ryu T., Azuma K., Yoshimura K., Yamanouchi Y., Ikehara S., and Kawamoto K. Expression of Rb2/p130 protein correlates with the degree of malignancy in gliomas. Brain Tumor Pathol. 21 (2004) 121-125